Glenmark USA launches Axitinib Tablets, 1 mg and 5 mg
Mumbai, Nov. 16 -- Glenmark Pharmaceuticals Inc., USA (Glenmark), today announced the launch of Axitinib Tablets, 1 mg and 5 mg. This product is an Authorized Generic version of INLYTA(R)1 (axitinib) tablets.
According to IQVIA(R) sales data for the 12-month period ending September 2026, U.S. annual sales of INLYTA(R) Tablets were approximately $538.4 million
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.